Raleigh Capital's ETF Rebalancing
Raleigh Capital Dramatically Adjusts ETF Holdings in Q1, Boosting Emerging Markets and Pharma
Key Points
Beyond Raleigh's activity, SPDR Portfolio Emerging Markets ETF (SPEM) drew notable attention from other large investors in the first quarter: Bravias Capital Group LLC increased its stake by 1.9% to 17,159 shares (about $805,000); Peak Financial Management Inc. owned 261,256 shares valued at about $12.26 million after purchasing 1,245 shares; WBH Advisory Inc. held 120,091 shares worth roughly $5.65 million after adding 18,060 shares; QRG Capital Management Inc. bought a new stake worth about $1.31 million; Apeiron RIA LLC increased to 22,146 shares worth about $1.04 million after an additional 883 shares.
In SPDR Bloomberg High Yield Bond ETF (JNK), Banque Cantonale Vaudoise expanded its stake by 13.3% in Q1 to 920 shares, a position valued at about $88,000 after buying 108 additional shares.
iShares 1-3 Year Treasury Bond ETF (SHY) saw substantial interest from Innova Wealth Partners, which increased its stake to 318,143 shares (about $26.27 million) after adding 182,540 shares in the quarter.
iShares U.S. Pharmaceuticals ETF (IHE) attracted several other hedge funds: Heritage Oak Wealth Advisors LLC opened a new position; Root Financial Partners LLC increased to 696 shares (up about 36.5% with 186 more shares); Cornerstone Wealth Group LLC raised its stake to 2,847 shares (up 13.7% with 342 more shares); AdvisorNet Financial Inc expanded to 40,993 shares (up 2.5% with 983 more shares).
In SPDR Portfolio Long Term Treasury ETF (SPTL), Drucker Wealth 3.0 LLC increased its stake to 85,485 shares (+421) as part of broader activity in the fund, with other institutions like Studio Investment Management LLC (+404), IHT Wealth Management LLC (+409), Bell Investment Advisors Inc (+418), and Elevated Capital Advisors LLC (+?) also expanding holdings during the period.
Raleigh Capital Management Inc. made sweeping changes to its ETF holdings in the first quarter, with some of the most dramatic percentage moves seen in recent filings. The firm nearly doubled its stake in SPDR Bloomberg High Yield Bond ETF (JNK) and made headline-grabbing buys in short-term Treasury and pharmaceutical funds, according to Watchlist News and Ticker Report.
The biggest headline number: Raleigh grew its position in iShares U.S. Pharmaceuticals ETF (IHE) by 865,800%, adding 8,658 shares to reach 8,659 total — worth about $751,000. Similarly, it boosted its iShares 1-3 Year Treasury Bond ETF (SHY) stake by 2,246,800%, adding 22,468 shares for a position worth roughly $1.86 million. Those eye-popping percentages reflect near-zero starting positions.
Raleigh Doubles Down on High Yield and Emerging Markets
Raleigh's most substantial position change in dollar terms was in SPDR Portfolio Emerging Markets ETF (SPEM). The firm added shares to reach 133,385 total, a 14.3% increase worth about $6.26 million. That makes SPEM its sixth-largest holding. The firm also lifted its JNK stake by 129.8% to 21,320 shares, valued at about $2.04 million, according to Watchlist News.
High yield bonds, like those held in JNK, carry more credit risk than government bonds but offer higher returns. Raleigh's big move into JNK signals a willingness to take on more risk in its fixed-income allocations. The firm also added 68,477 shares of SPDR Portfolio Long Term Corporate Bond ETF (SPLB), growing that position by 236.1% to 97,476 shares, per Ticker Report.
Raleigh Slashes Long-Term Treasury Exposure by Half
Not every move was a buy. Raleigh cut its position in SPDR Portfolio Long Term Treasury ETF (SPTL) by 52.1%, dropping to 57,633 shares worth about $1.52 million. Long-term Treasury bonds lose value when interest rates rise, so trimming that position could reflect a bet that rates will stay higher for longer.
While Raleigh was selling SPTL, others were buying. Drucker Wealth 3.0 LLC added 421 shares to reach 85,485. Studio Investment Management LLC, IHT Wealth Management LLC, Bell Investment Advisors Inc., and Elevated Capital Advisors LLC also expanded their SPTL holdings during the quarter. The diverging moves show investors are split on where long-term rates are headed.
Other Big Investors Piled Into SPEM and SHY Alongside Raleigh
Raleigh was not alone in loading up on SPEM. Peak Financial Management Inc. held 261,256 shares worth about $12.26 million. WBH Advisory Inc. held 120,091 shares worth roughly $5.65 million after adding 18,060 shares in the quarter. QRG Capital Management Inc. opened a brand-new stake worth about $1.31 million. Apeiron RIA LLC also added shares, reaching 22,146 worth about $1.04 million.
In the short-term Treasury space, Innova Wealth Partners made the quarter's biggest SHY move. The firm added 182,540 shares, bringing its total to 318,143 shares worth about $26.27 million. That dwarfs Raleigh's $1.86 million SHY position. Short-term Treasuries like SHY are popular when investors want safety and steady income without taking on much interest rate risk.
Pharma ETF Draws Fresh Money From Multiple Firms
Raleigh's 865,800% jump into iShares U.S. Pharmaceuticals ETF (IHE) was dramatic in percentage terms, but several other firms also moved into the fund. Heritage Oak Wealth Advisors LLC opened a brand-new position. Root Financial Partners LLC raised its stake by about 36.5%, adding 186 shares to reach 696. Cornerstone Wealth Group LLC grew to 2,847 shares, up 13.7% with 342 new shares added.
AdvisorNet Financial Inc made the largest existing-holder increase, adding 983 shares to reach 40,993 — a 2.5% bump. The coordinated interest across firms suggests growing confidence in the pharmaceutical sector. Meanwhile, Raleigh also opened a new position in Principal Financial Group (PFG), buying 7,803 shares worth about $703,000, per Ticker Report, pointing to broader diversification beyond just ETFs.
Sentiment
Mostly PositivePublishers
23
Articles
6
Reach
29
